A new systematic review suggests that monoclonal antibodies and JAK inhibitors may offer meaningful symptom relief and improved sunlight tolerance for several photosensitive skin disorders, including chronic actinic dermatitis, actinic prurigo, solar urticaria, photoaggravated eczema, photoaggravated psoriasis, and polymorphic light eruption. Although t…
